More from Healthcare
With prices in a downtrend with a $95 price target, hold off on purchases until prices hold for the drugmaker.
ABMD has been one of the best-performing stocks in the S&P 500 over the past five years.
All the charts of the molecular diagnostics company look bullish.
EW has had some corrections and pullbacks along the way during this long and strong rally from $80 to nearly $200, but its price target is $240.